Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines
CONCLUSIONS: The conjugate vaccines use with different serotype coverage conditioned a decrease of the vaccine-included and an increase of non-covered. Despite these changes, the global antimicrobial susceptibility patterns to erythromycin and levofloxacin maintained relatively stables. The resistance a penicillin was low, not finding this type of resistant strains in the last study period.PMID:37873744 | DOI:10.37201/req/034.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 24, 2023 Category: Drugs & Pharmacology Authors: G Zaragoza Vargas J Cacho Calvo R Mart ínez-Arce D Molina Arana B Ramos Bl ázquez M P érez Abeledo J C Sanz Moreno Source Type: research
Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines
CONCLUSIONS: The conjugate vaccines use with different serotype coverage conditioned a decrease of the vaccine-included and an increase of non-covered. Despite these changes, the global antimicrobial susceptibility patterns to erythromycin and levofloxacin maintained relatively stables. The resistance a penicillin was low, not finding this type of resistant strains in the last study period.PMID:37873744 | DOI:10.37201/req/034.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 24, 2023 Category: Drugs & Pharmacology Authors: G Zaragoza Vargas J Cacho Calvo R Mart ínez-Arce D Molina Arana B Ramos Bl ázquez M P érez Abeledo J C Sanz Moreno Source Type: research
Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines
CONCLUSIONS: The conjugate vaccines use with different serotype coverage conditioned a decrease of the vaccine-included and an increase of non-covered. Despite these changes, the global antimicrobial susceptibility patterns to erythromycin and levofloxacin maintained relatively stables. The resistance a penicillin was low, not finding this type of resistant strains in the last study period.PMID:37873744 | DOI:10.37201/req/034.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 24, 2023 Category: Drugs & Pharmacology Authors: G Zaragoza Vargas J Cacho Calvo R Mart ínez-Arce D Molina Arana B Ramos Bl ázquez M P érez Abeledo J C Sanz Moreno Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
Rev Esp Quimioter. 2023 Oct 11:moreno11oct2023. doi: 10.37201/req/055.2023. Online ahead of print.NO ABSTRACTPMID:37818986 | DOI:10.37201/req/055.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 11, 2023 Category: Drugs & Pharmacology Authors: J Moreno Izarra A Brunst J A Carmona Álvarez F Aranda J M M ártir Alario Source Type: research
Prosthesis joint infection due to Clostridioides difficile and literature review
Rev Esp Quimioter. 2023 Oct 10:astor10oct2023. doi: 10.37201/req/037.2023. Online ahead of print.NO ABSTRACTPMID:37814780 | DOI:10.37201/req/037.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 10, 2023 Category: Drugs & Pharmacology Authors: S Astor Molero N V ázquez-Temprano P Camacho Zamora X Sola Mallo P Álvarez García J C Rodr íguez García Source Type: research
Prosthesis joint infection due to Clostridioides difficile and literature review
Rev Esp Quimioter. 2023 Oct 10:astor10oct2023. doi: 10.37201/req/037.2023. Online ahead of print.NO ABSTRACTPMID:37814780 | DOI:10.37201/req/037.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 10, 2023 Category: Drugs & Pharmacology Authors: S Astor Molero N V ázquez-Temprano X Sola Mallo P Álvarez García J C Rodr íguez García Source Type: research
